Manipal Health Advances Towards Rs 10,000-Crore IPO Following Sebi Approval.

Manipal Health Enterprises, backed by Temasek, has received approval from the Securities and Exchange Board of India (Sebi) for its upcoming initial public offering (IPO). This strategic move is part of the company’s plan to raise up to $1.2 billion, which translates to approximately ₹10,000 crore. The IPO will consist of a combination of fresh shares and an offer-for-sale by existing shareholders, allowing the company to enhance its capital position while providing liquidity to early investors.

The proceeds from the fresh issue are earmarked for critical financial maneuvers, with around ₹5,378 crore designated for repaying borrowings related to its subsidiary, Manipal Hospitals. Additionally, ₹574 crore is set to fund the acquisition of a stake in Sahyadri Hospitals, further strengthening Manipal’s foothold in the healthcare sector. Such moves are likely to bolster the company’s operational capacity and improve its financial health, which are positive signals for potential investors.

As this IPO approaches, early grey market sentiment appears to be cautiously optimistic, indicating potential interest among investors. This enthusiasm may be driven by the ongoing consolidation in the Indian healthcare sector and the strong backing of Temasek. For Indian investors, this IPO presents an attractive opportunity to invest in a well-placed entity within a rapidly growing industry. Given the robust plans for debt reduction and expansion, investors may find long-term value within Manipal Health Enterprises’ offerings.

Source: The Economic Times

(Expert Note: This report was prepared by the Wealthova IPO team.)